Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY Advertising Drives 44% Income Growth Ahead of Carlyle Acquisition

This article was originally published in The Tan Sheet

Executive Summary

NBTY says television advertising behind its brands spurred 44 percent growth in net income to $66 million in its latest quarter

You may also be interested in...



Swanson Health Sale Could Lead Private Equity Spike In Supplement Space

Swander Pace Capital's Swanson Health deal announced Jan. 25 is the firm's second in two months in the supplement industry after acquiring Captek Softgel in December. OTC drug and supplement firms in 2016 could be among the consumer product spaces targeted in likely higher private equity investing.

NBTY Appoints GE Vet To Succeed CEO Rudolph

Newly private NBTY replaces long-time CEO Scott Rudolph with Jeffrey Nagel, a company outsider and supplement industry newcomer.

NBTY Appoints GE Vet To Succeed CEO Rudolph

Newly private NBTY replaces long-time CEO Scott Rudolph with Jeffrey Nagel, a company outsider and supplement industry newcomer.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel